Cardiology — Preoperative Cardiac Clearance Template
The Preoperative Cardiac Clearance Template is designed for cardiologists evaluating patients for non-cardiac surgery. This template documents surgical risk assessment, functional capacity evaluation, cardiac history review, and perioperative management recommendations following ACC/AHA guidelines. Supports appropriate billing for preoperative consultations (99243-99245) and includes sections for surgical risk stratification, functional capacity assessment, active cardiac conditions, and perioperative medication management. Ideal for consultative cardiology practices and preoperative assessment clinics.
Template
Consultation Information
Referring physician: [Name, specialty]
Reason for consultation: Preoperative cardiac evaluation
Date of evaluation: [Date]
Planned surgery: [Procedure name]
Planned surgery date: [Date]
Surgical facility: [Hospital/ASC name]
Anesthesia type: General / Regional / MAC / Local
Proposed Surgical Procedure
Procedure: [Detailed description]
Surgical risk category (ACC/AHA):
- Low risk (<1% MACE): Yes / No
- Elevated risk (≥1% MACE): Yes / No
Specific procedure risk factors: [Vascular, intrathoracic, intraperitoneal, orthopedic, etc.]
Estimated blood loss: Minimal / Moderate / Significant
Estimated duration: [X] hours
Emergency vs elective: Elective / Urgent / Emergency
Functional Capacity Assessment
Can patient climb 2 flights of stairs without stopping? Yes / No
Can patient walk 4 blocks on level ground? Yes / No
Can patient do heavy housework (scrubbing floors, lifting)? Yes / No
Estimated METs:
- ≥4 METs (adequate): Yes / No
- <4 METs (poor): Yes / No
- Unable to assess: Yes / No — Reason: [Orthopedic limitation, deconditioning, etc.]
DASI Score (if calculated): [X] — Estimated METs: [X]
Cardiac History
Coronary artery disease: None / [History: MI dates, PCI dates, CABG date]
- Last cardiac catheterization: [Date, findings]
- Stent type if PCI: BMS / DES — Date placed: [X]
Heart failure: None / HFrEF / HFpEF — EF: [X]%
- Compensated: Yes / No
Valvular disease: None / [Valve, severity]
- Moderate-severe AS: Yes / No (critical for risk)
Arrhythmias: None / AFib / Other [specify]
- Pacemaker/ICD: Yes / No — Type: [X]
Pulmonary hypertension: None / [Severity if known]
Congenital heart disease: None / [Details]
Active Cardiac Conditions (ACC/AHA)
Check all that apply:
[ ] Unstable coronary syndromes (unstable angina, recent MI)
[ ] Decompensated heart failure
[ ] Significant arrhythmias (high-grade AV block, symptomatic ventricular arrhythmias, SVT with uncontrolled rate, symptomatic bradycardia, new VT)
[ ] Severe valvular disease (severe AS, symptomatic MS)
Active cardiac conditions present: Yes / No
If YES: Surgery should be delayed for evaluation and treatment
Clinical Risk Factors (RCRI)
Revised Cardiac Risk Index:
[ ] High-risk surgery (1 point)
[ ] History of ischemic heart disease (1 point)
[ ] History of heart failure (1 point)
[ ] History of cerebrovascular disease (1 point)
[ ] Diabetes requiring insulin (1 point)
[ ] Creatinine >2.0 mg/dL (1 point)
RCRI Score: [0-6]
Estimated MACE risk: [<1% / 1-5% / 5-10% / >10%]
Cardiovascular Risk Factors
Hypertension: Yes / No — Controlled: Yes / No
Diabetes: Yes / No — Type [1/2], A1c: [X]%
Hyperlipidemia: Yes / No — On statin: Yes / No
Smoking: Current / Former / Never
Obesity: Yes / No — BMI: [X]
CKD: Yes / No — GFR: [X]
Age: [X] years
Current Cardiac Medications
Antiplatelet agents:
- Aspirin: [Dose] — Continue / Hold [X days]
- P2Y12 inhibitor: [Drug, dose] — Continue / Hold [X days]
- Indication: Recent stent (<12 months DES, <30 days BMS) / ACS / Other
Anticoagulants:
- [Agent, dose] — Continue / Hold / Bridge
- Indication: [AFib, mechanical valve, VTE]
Beta-blockers: [Drug, dose] — Continue perioperatively
ACEi/ARB: [Drug, dose] — Continue / Hold day of surgery
Diuretics: [Drug, dose] — Hold day of surgery / Continue
Statins: [Drug, dose] — Continue perioperatively
Other: [List]
Physical Examination
Vital signs: BP [X/X], HR [X], RR [X], SpO2 [X]%
General: [Appearance, distress level]
Cardiovascular:
- JVP: Normal / Elevated [X cm]
- Carotid: Normal / Bruit / Diminished
- Heart rhythm: Regular / Irregular
- Murmurs: None / [Grade, location, timing]
- AS murmur characteristics: [If applicable]
- S3/S4: Absent / Present
- Edema: None / [Grade, location]
Lungs: Clear / [Findings]
Peripheral pulses: [Assessment]
Diagnostic Studies
ECG: [Date, rhythm, rate, intervals, ischemic changes, conduction abnormalities]
- New findings: Yes / No
Echocardiogram: [Date if recent]
- EF: [X]%
- Wall motion: Normal / [Abnormalities]
- Valves: [Assessment, especially AS severity]
- RVSP: [X] mmHg
Stress test: [Date, type, result if recent]
- Ischemia: None / [Location, extent]
- Functional capacity: [METs achieved]
Labs: Cr [X], GFR [X], Hgb [X], BNP [X if obtained]
Risk Assessment Summary
Surgical risk: Low / Elevated
Functional capacity: ≥4 METs / <4 METs / Unable to assess
Active cardiac conditions: Present / Absent
RCRI Score: [X] — Estimated MACE: [X]%
Combined perioperative MACE risk: Low (<1%) / Intermediate (1-5%) / High (>5%)
Recommendations
Preoperative Testing
Additional testing needed: Yes / No
- [ ] Echocardiogram — Indication: [Dyspnea, murmur, HF symptoms]
- [ ] Stress testing — Indication: [Poor functional capacity + elevated surgical risk + will change management]
- [ ] Cardiac catheterization — Indication: [High-risk features on stress test]
Rationale: [Why testing is/is not indicated per ACC/AHA guidelines]
Perioperative Medication Management
1) Beta-blockers:
- Continue current beta-blocker perioperatively
- Do NOT initiate high-dose beta-blocker on day of surgery
2) Antiplatelet therapy:
- Aspirin: [Continue / Hold X days preop / Resume postop day X]
- P2Y12 inhibitor: [Continue / Hold X days preop / Resume postop day X]
- Dual antiplatelet delay: [If recent stent, minimum time to delay surgery]
3) Anticoagulation:
- [Agent]: [Continue / Hold X days / Bridge with LMWH]
- Resume: [Timing postoperatively]
4) ACEi/ARB: Hold morning of surgery, resume when hemodynamically stable
5) Statins: Continue perioperatively
6) Diuretics: [Hold / Continue] day of surgery
Device Management (if applicable)
Pacemaker/ICD present: Yes / No
- Interrogation needed preop: Yes / No
- Reprogramming needed: [Magnet mode, disable tachy therapy]
- Electrocautery precautions: [Recommendations]
- Postop interrogation: Yes / No
Surgical Clearance
Cardiac clearance for surgery: GRANTED / DEFERRED / NOT GRANTED
Conditions for clearance:
- [List any conditions that must be met]
Risk acknowledged: Patient is at [low/intermediate/high] cardiac risk for this procedure
Follow-up
Preoperative: [Any additional testing or visits needed]
Postoperative: [Cardiology follow-up timing]
- Telemetry recommended: Yes / No — Duration: [X] hours
- Troponin monitoring: Yes / No — Indication: [High-risk patient]
Communication
Discussed with:
- Patient: [Risks, recommendations, questions addressed]
- Surgeon: [Name, discussed risk and recommendations]
- Anesthesia: [If applicable]
Report sent to: [Surgeon, PCP, surgical facility]
Summary Statement
[Patient name] is a [age]-year-old [male/female] with [cardiac history summary] presenting for preoperative cardiac evaluation prior to [procedure]. Surgical risk is [low/elevated]. Functional capacity is [adequate/poor/unable to assess]. RCRI score is [X] with estimated MACE risk of [X]%. [No active cardiac conditions are present / Active cardiac conditions include X].
Based on ACC/AHA guidelines, [additional testing is/is not indicated]. The patient is [cleared / conditionally cleared / not cleared] for surgery with the above recommendations for perioperative medication management.
💡 Tip: Click anywhere to edit. Changes are temporary.
Related templates
Automate Your Documentation
Use this template with OrbVoice AI medical scribe to automatically generate structured notes from patient conversations. Save 2+ hours daily while maintaining documentation quality.